Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Clinical research trials and Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation. Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation clinical trial. Human subjects often receive the most effective healthcare possible for their Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "C" Clinical Trials Conditions > Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation



Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

For Condition: Leukemia,Lymphoma,Multiple Myeloma
Status: No longer recruiting
Sponsor(s): National Cancer Institute (NCI) , Robert H. Lurie Cancer Center
Synopsis: RATIONALE: Captopril may protect the lungs from the side effects of bone marrow or stem cell transplantation. PURPOSE: Randomized phase III trial to determine the effectiveness of captopril to lessen the side effects in patients who are undergoing bone marrow or stem cell transplantation following chemotherapy and radiation therapy.
Details: OBJECTIVES: I. Determine if captopril can block or prevent lung injury in patients undergoing autologous bone marrow or stem cell transplantation following cyclophosphamide and total body radiotherapy or high dose chemotherapy. II. Determine a series of surrogate lung injury prediction markers for monitoring patients undergoing therapy. PROTOCOL OUTLINE: This is a randomized study. Patients are stratified according to preparative regimen (high dose chemotherapy versus cyclophosphamide and total body radiotherapy). Patients are randomized into one of two treatment arms. All patients undergo a conditioning regimen consisting of cyclophosphamide daily on days -6 and -5 and total body radiotherapy on day -4 through -1, or high dose chemotherapy per transplantation protocol. Arm I: Patients receive oral captopril 2 to 3 times daily beginning on the first day of the conditioning regimen and continuing until day 100 post autologous bone marrow or stem cell transplantation. Arm II: Patients receive no captopril while undergoing conditioning therapy. Patients are followed at 6 months. PROJECTED ACCRUAL: A total of 35 patients will be accrued for this study.
Eligibility:
Study Type:  Interventional,�Educational/Counseling/Training
Minimum Age/Maximum Age: /
Genders: 
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Eligible for existing autologous bone marrow or stem cell transplantation protocols using either a high dose chemotherapy regimen or a cyclophosphamide and total body radiotherapy regimen --Prior/Concurrent Therapy-- - See Disease Characteristics - No prior captopril or other ACE inhibitors --Patient Characteristics-- - Age: Not specified - Performance status: Not specified - Life expectancy: Not specified - Hematopoietic: Not specified - Hepatic: Not specified - Renal: Not specified - Other: No other concurrent medical illness that would preclude study
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
LeoGordon,  Study Chair,  Robert H. Lurie Cancer Center

Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago,  Illinois,  60611
United States
 


Additional Information:
Study ID Numbers:  CDR0000067472;  NU-98CC1,NCI-G99-1658
Study Start Date: October 1999
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004230

Other Lymphoma Studies:
1. T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

2. Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

3. A Phase II Study of Continuous versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma

4. PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

5. A Study of PS-341 Given to Patients With Multiple Myeloma who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

Related Studies:

Other Lymphoma Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
Modify your Search

  Other Lymphoma Clinical Trials
  Other Illinois Clinical Trials
  Other Chicago Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103